11-bromovincamine has been researched along with Day Blindness in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichien, K; Kitazawa, Y; Okabe, I; Sawada, A; Yamamoto, T | 1 |
1 trial(s) available for 11-bromovincamine and Day Blindness
| Article | Year |
|---|---|
Prevention of visual field defect progression with brovincamine in eyes with normal-tension glaucoma.
Topics: Administration, Oral; Calcium Channel Blockers; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Prospective Studies; Vasodilator Agents; Vincamine; Vision Disorders; Visual Acuity; Visual Fields | 1996 |